Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2001 AND VI 19 AND IP 1
Results: 10
1
2
An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada.
- Published in:
- 2001
- By:
- Publication type:
- journal article
3
A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis.
- Published in:
- 2001
- By:
- Publication type:
- journal article
4
Enteroviral meningitis. Cost of illness and considerations for the economic evaluation of potential therapies.
- Published in:
- 2001
- By:
- Publication type:
- journal article
5
The cost of HIV treatment and care. A global review.
- Published in:
- 2001
- By:
- Publication type:
- journal article
6
Glycoprotein IIb/IIIa receptor therapy in percutaneous coronary intervention and non-ST-segment elevation acute coronary syndromes. Estimating the economic implications.
- Published in:
- 2001
- By:
- Publication type:
- journal article
7
Dermatan sulfate versus unfractionated heparin for the prevention of venous thromboembolism in patients undergoing surgery for cancer. A cost-effectiveness analysis.
- Published in:
- 2001
- By:
- Publication type:
- journal article
8
A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France.
- Published in:
- 2001
- By:
- Publication type:
- journal article
9
Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
- Published in:
- 2001
- By:
- Publication type:
- journal article
10
Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy.
- Published in:
- 2001
- By:
- Publication type:
- journal article